▁There 5.83203125
▁is 1.626953125
▁currently 4.72265625
▁a 1.4619140625
▁severe 5.44140625
▁lack 2.92578125
▁of 0.0206146240234375
▁information 3.65625
▁about 1.4462890625
▁the 0.7919921875
▁effects 3.875
▁of 0.1082763671875
▁op 6.61328125
i 3.775390625
ates 0.028350830078125
. 3.91015625
▁They 5.02734375
▁manage 9.1875
▁pain 2.126953125
▁successfully 6.66796875
, 1.00390625
▁but 0.283447265625
▁the 2.6328125
▁past 8.8984375
▁few 1.150390625
▁dec 1.5859375
ades 3.6597251892089844e-05
▁indicated 9.8828125
▁the 2.80859375
▁growing 3.595703125
▁concern 3.19140625
▁regarding 3.37109375
▁op 1.9833984375
iate 0.40185546875
▁ab 1.3798828125
use 0.0094146728515625
▁in 3.419921875
▁forms 9.8515625
▁of 0.2381591796875
▁over 3.35546875
d 0.0738525390625
ose 0.31982421875
▁and 0.79541015625
▁add 0.52490234375
iction 0.01433563232421875
. 0.09808349609375
▁A 4.12890625
▁more 5.3828125
▁manage 9.1015625
able 0.00284576416015625
▁and 2.099609375
▁sa 2.26171875
fer 0.0001596212387084961
▁alternative 1.9326171875
▁might 4.98046875
▁be 0.2481689453125
▁medical 5.8203125
▁mar 0.386474609375
iju 0.0010805130004882812
ana 4.756450653076172e-05
. 0.61962890625
▁However 4.3359375
, 0.0156707763671875
▁the 1.8798828125
▁legal 3.5546875
▁status 1.0693359375
▁and 3.41015625
▁novel 10.4609375
ty 0.212646484375
▁of 0.1463623046875
▁this 1.8681640625
▁drug 1.962890625
▁do 4.91796875
▁not 0.0391845703125
▁allow 0.98291015625
▁finding 7.9765625
▁a 2.63671875
▁large 3.37890625
▁number 0.97216796875
▁of 0.004169464111328125
▁studies 0.923828125
▁on 1.787109375
▁its 1.1279296875
▁effect 2.193359375
iveness 0.181640625
. 0.6806640625
▁Specifically 8.984375
, 0.08868408203125
▁it 2.787109375
▁concerns 5.34375
▁the 0.99365234375
▁emot 9.828125
ional 0.0372314453125
▁condition 5.36328125
▁of 0.623046875
▁patients 1.1826171875
▁experien 6.1328125
cing 9.5367431640625e-05
▁chron 1.0595703125
ic 0.0005893707275390625
▁pain 0.08697509765625
. 0.386474609375
▁This 3.044921875
▁research 2.75390625
▁paper 2.28125
▁a 1.650390625
ims 0.0002751350402832031
▁to 0.128662109375
▁analyze 2.8046875
▁levels 10.6796875
▁of 0.037017822265625
▁de 1.8427734375
pression 0.055816650390625
▁and 0.67919921875
▁anx 0.1328125
iety 0.0002694129943847656
▁among 1.494140625
▁people 2.515625
▁receiving 4.2109375
▁ther 4.98046875
apy 0.0355224609375
▁by 4.61328125
▁comparing 10.3046875
▁the 1.875
▁effects 2.451171875
▁of 0.0289154052734375
▁ph 5.6328125
arma 0.354736328125
ce 0.01131439208984375
ut 0.0002663135528564453
ical 0.0173492431640625
▁op 1.4140625
io 2.65625
ids 0.09234619140625
▁and 0.501953125
▁MM 4.1953125
. 2.421875
<0x0A> 0.3994140625
Chr 4.12109375
onic 0.00745391845703125
▁pain 0.141845703125
▁is 0.876953125
▁still 6.37890625
▁considered 3.005859375
▁to 1.7548828125
▁be 0.039764404296875
▁an 2.83984375
▁extreme 6.6328125
▁issue 3.474609375
▁among 3.251953125
▁at 9.375
▁least 0.09423828125
▁ 0.348388671875
8 3.80078125
% 1.837890625
▁of 0.050384521484375
▁the 0.7275390625
▁residents 7.52734375
▁of 0.364013671875
▁progress 12.078125
ive 0.12213134765625
▁countries 0.44775390625
. 0.453369140625
▁The 2.078125
▁introduction 6.95703125
▁of 0.014404296875
▁the 3.111328125
▁study 6.71875
▁describes 5.32421875
▁the 0.55810546875
▁apparent 9.1796875
▁link 3.7109375
▁between 0.08013916015625
▁pain 2.134765625
▁and 0.358642578125
▁dem 9.15625
oral 1.4599609375
ization 0.06976318359375
. 0.8271484375
▁Chron 4.58984375
ic 0.00878143310546875
▁pain 0.192138671875
▁is 1.5009765625
▁always 5.421875
▁accompanied 1.544921875
▁by 0.053802490234375
▁negative 3.892578125
▁emot 0.501953125
ional 1.169921875
▁experiences 3.173828125
▁and 2.50390625
▁blocks 11.4375
▁a 2.87890625
▁person 0.75537109375
’ 0.66259765625
s 0.0014362335205078125
▁ability 1.1796875
▁to 0.02301025390625
▁receive 6.49609375
▁joy 3.3515625
▁and 1.6748046875
▁satisfaction 2.353515625
▁from 0.701171875
▁life 0.822265625
. 0.225830078125
▁The 1.9384765625
▁research 2.76171875
▁investig 5.89453125
ates 0.30859375
▁the 0.5146484375
▁development 6.890625
▁of 0.053253173828125
▁de 1.0048828125
pression 0.1514892578125
▁and 0.264892578125
▁anx 0.048919677734375
iety 0.0004925727844238281
▁among 1.142578125
▁patients 0.9794921875
▁receiving 2.26171875
▁ph 3.09765625
arma 0.096923828125
ce 0.003082275390625
ut 1.6570091247558594e-05
ical 0.006038665771484375
▁op 0.69580078125
io 0.262939453125
ids 0.12548828125
▁and 0.7666015625
▁medical 1.177734375
▁mar 0.1038818359375
iju 0.0004916191101074219
ana 2.86102294921875e-05
▁( 2.810546875
MM 0.456298828125
) 1.2490234375
▁as 1.7734375
▁severe 10.3203125
▁pain 0.498046875
kill 2.56640625
ers 0.0002315044403076172
. 0.138427734375
▁It 2.98046875
▁comp 4.20703125
ares 0.006404876708984375
▁the 0.484130859375
▁effic 4.37109375
acy 0.00310516357421875
▁of 0.2132568359375
▁pres 6.453125
cri 2.5
ptions 0.82177734375
▁and 1.3818359375
▁exam 4.65625
ines 0.00708770751953125
▁the 0.59619140625
▁possibility 3.775390625
▁of 0.1256103515625
▁post 9.5
- 0.962890625
tre 1.578125
at 0.00186920166015625
ment 0.0032367706298828125
▁de 1.4560546875
pression 0.053802490234375
. 1.4248046875
<0x0A> 0.462890625
The 0.68798828125
▁study 1.7861328125
▁was 2.466796875
▁conducted 0.59716796875
▁in 1.220703125
▁the 1.416015625
▁form 2.5390625
▁of 0.001583099365234375
▁collection 11.625
▁and 0.68310546875
▁analysis 0.35888671875
▁of 0.010223388671875
▁statistical 3.703125
▁data 0.11444091796875
. 0.79931640625
▁Part 5.109375
icip 0.1767578125
ants 0.058013916015625
▁were 0.67529296875
▁rec 3.85546875
ru 0.0011281967163085938
ited 0.00019156932830810547
▁for 4.12109375
▁six 6.50390625
▁months 0.54248046875
▁at 4.21484375
▁two 2.7265625
▁major 4.015625
▁pain 2.69921875
▁relief 4.203125
▁cent 0.76513671875
ers 0.0281219482421875
▁in 0.7138671875
▁Israel 5.50390625
. 0.300537109375
▁The 1.2421875
▁research 2.27734375
ers 1.3408203125
▁used 2.263671875
▁The 7.359375
▁De 3.177734375
pression 0.024017333984375
▁Module 6.55078125
▁of 0.73828125
▁the 0.2132568359375
▁Pat 3.173828125
ient 0.0104217529296875
▁Health 0.039764404296875
▁Question 0.019622802734375
naire 0.0278472900390625
▁and 2.638671875
▁the 0.82373046875
▁General 1.201171875
ized 0.6875
▁An 0.005069732666015625
x 0.0001163482666015625
iety 0.0003962516784667969
▁Dis 0.133056640625
order 0.0215301513671875
▁Sc 1.4619140625
ale 0.002719879150390625
▁to 0.86376953125
▁interview 7.546875
▁participants 2.646484375
, 4.4921875
▁evaluate 4.46484375
▁their 0.58056640625
▁answers 4.14453125
, 0.257080078125
▁and 0.029510498046875
▁conduct 4.90234375
▁the 1.8916015625
▁study 2.306640625
. 0.10284423828125
▁To 4.96875
▁specifically 10.078125
▁evaluate 3.451171875
▁and 5.1953125
▁compare 0.517578125
▁the 0.423095703125
▁prob 9.8671875
abilities 0.039947509765625
▁of 0.0689697265625
▁de 0.91845703125
pression 0.03302001953125
▁or 4.45703125
▁anx 0.047149658203125
iety 0.0005350112915039062
▁among 1.568359375
▁the 2.1328125
▁diverse 9.40625
▁groups 0.80078125
, 0.68505859375
▁the 0.410400390625
▁study 2.68359375
▁used 1.3203125
▁multiple 5.26953125
▁log 0.6103515625
istic 0.02685546875
▁regression 0.297607421875
▁analysis 1.392578125
▁and 2.75
▁chose 8.5625
▁medical 6.25390625
▁mar 0.09423828125
iju 0.0010004043579101562
ana 3.981590270996094e-05
▁as 0.5537109375
▁the 0.873046875
▁control 2.8359375
▁group 0.61865234375
. 0.263916015625
<0x0A> 0.349365234375
This 4.0859375
▁type 5.79296875
▁of 0.00206756591796875
▁study 1.3955078125
▁is 1.287109375
▁the 3.623046875
▁most 1.26171875
▁reve 7.9765625
aling 0.0005035400390625
▁and 1.4619140625
▁inclus 7.03515625
ive 0.0007433891296386719
, 3.115234375
▁as 1.2548828125
▁it 0.341796875
▁contains 4.62890625
▁direct 5.984375
▁responses 5.51953125
▁from 0.5791015625
▁a 3.59375
▁large 0.90869140625
▁number 0.448974609375
▁of 0.0022716522216796875
▁participants 0.93701171875
. 0.53466796875
▁All 5.328125
▁tools 7.81640625
▁in 5.7578125
▁the 0.80419921875
▁form 3.9296875
▁of 0.019317626953125
▁question 0.7158203125
na 0.013702392578125
ires 0.00035309791564941406
▁and 1.2041015625
▁scales 2.6640625
▁have 3.435546875
▁already 3.935546875
▁been 0.41162109375
▁used 2.18359375
▁and 1.849609375
▁proved 2.369140625
▁their 1.4462890625
▁effic 2.5390625
acy 0.00276947021484375
▁for 3.578125
▁collect 4.01171875
ing 0.003559112548828125
▁analyt 7.25
ical 0.09228515625
▁data 0.1673583984375
. 0.335693359375
▁It 3.22265625
▁helps 4.23828125
▁to 0.6953125
▁system 6.96875
at 0.53955078125
ize 0.001697540283203125
▁and 1.2958984375
▁class 4.87890625
ify 0.0018663406372070312
▁distinct 8.1796875
▁kinds 6.37109375
▁of 0.0151214599609375
▁information 2.30078125
▁for 4.015625
▁subsequent 5.11328125
▁un 8.78125
comp 4.4296875
licated 0.024932861328125
▁services 12.59375
. 0.54443359375
▁Thus 4.76171875
, 0.003971099853515625
▁research 4.28515625
ers 0.2275390625
▁can 1.6474609375
▁compare 2.5
▁the 1.0224609375
▁effects 2.755859375
▁of 0.09307861328125
▁medic 3.75390625
ations 0.62451171875
▁on 1.6669921875
▁patients 2.005859375
▁of 4.2265625
▁diverse 2.984375
▁age 1.958984375
▁groups 2.28125
, 0.74169921875
▁background 3.703125
s 0.1141357421875
, 0.01214599609375
▁physical 5.69140625
▁conditions 1.3583984375
, 0.028594970703125
▁emot 6.38671875
ional 0.0305023193359375
▁states 1.345703125
, 0.03643798828125
▁and 0.3779296875
▁so 2.56640625
▁on 0.203125
. 0.0626220703125
<0x0A> 0.78271484375
The 0.7333984375
▁question 6.40625
na 0.884765625
ires 0.00012612342834472656
▁used 1.8720703125
▁different 9.5390625
▁variable 9.15625
▁measures 4.36328125
▁to 1.3330078125
▁collect 2.630859375
▁information 1.4951171875
. 1.28125
▁For 2.1953125
▁example 0.49169921875
, 0.0023441314697265625
▁it 4.1640625
▁included 1.7392578125
▁compreh 8.515625
ensive 0.093505859375
▁so 6.09765625
cio 0.0015020370483398438
- 0.317626953125
dem 0.1375732421875
ographic 0.061065673828125
▁data 0.90185546875
: 5.16015625
▁gender 2.0390625
, 0.044036865234375
▁age 0.2493896484375
, 0.033599853515625
▁country 4.10546875
, 2.3046875
▁type 4.51171875
▁of 0.049774169921875
▁residence 3.56640625
▁( 2.61328125
urban 0.7216796875
/ 1.51953125
r 0.1370849609375
ural 0.000988006591796875
), 0.184814453125
▁years 6.3125
▁of 0.153076171875
▁education 0.59326171875
, 0.09173583984375
▁and 1.361328125
▁employ 2.421875
ment 0.0018968582153320312
▁status 0.79248046875
. 0.1146240234375
▁Pat 5.171875
ients 0.11932373046875
▁were 1.1806640625
▁also 0.853515625
▁asked 0.712890625
▁about 0.84619140625
▁their 0.61767578125
▁medical 2.37109375
▁history 0.51708984375
▁over 8.6640625
▁the 0.066162109375
▁years 4.484375
▁and 1.6748046875
▁the 1.4736328125
▁current 2.919921875
▁presence 4.859375
▁of 0.0836181640625
▁any 2.21484375
▁severe 4.00390625
▁dise 2.068359375
ases 7.295608520507812e-05
▁such 4.59375
▁as 0.0011720657348632812
▁heart 2.607421875
▁failure 1.787109375
, 0.283203125
▁di 1.529296875
ab 0.0008158683776855469
etes 0.0023040771484375
, 0.0631103515625
▁ar 3.93359375
th 0.154052734375
rit 0.0274658203125
is 0.004241943359375
, 0.02362060546875
▁and 1.2958984375
▁so 1.0029296875
▁on 0.0677490234375
. 0.02618408203125
▁The 1.6416015625
▁third 6.6484375
▁measure 4.4140625
▁of 2.52734375
▁the 0.865234375
▁question 1.0703125
naire 0.2705078125
▁was 1.1357421875
▁indicated 10.796875
▁by 1.39453125
▁information 6.44140625
▁on 2.03515625
▁any 5.1640625
▁twelve 13.984375
- 0.1754150390625
month 0.1610107421875
▁and 5.1953125
▁lifetime 0.85302734375
▁drug 3.4765625
▁and 1.9228515625
▁alco 0.133544921875
hol 7.200241088867188e-05
▁consumption 4.12109375
. 0.364501953125
▁In 3.787109375
▁addition 0.79541015625
, 0.1881103515625
▁the 1.109375
▁record 9.4609375
▁included 1.345703125
▁a 2.7265625
▁pain 4.359375
▁measurement 4.69921875
▁scale 0.93994140625
▁from 4.00390625
▁ 0.496826171875
0 0.296875
▁to 0.201171875
▁ 0.006862640380859375
1 0.066162109375
0 0.0367431640625
▁to 3.15625
▁evaluate 1.7607421875
▁dis 5.9765625
com 0.09588623046875
fort 0.0002720355987548828
▁feelings 8.15625
▁during 3.79296875
▁the 0.309814453125
▁last 1.259765625
▁month 1.5986328125
. 0.169189453125
<0x0A> 0.51708984375
The 0.84765625
▁analysis 3.625
▁of 0.64599609375
▁any 8.59375
▁human 7.3671875
▁reaction 4.3671875
▁has 4.9609375
▁a 1.8291015625
▁high 3.3671875
▁potential 3.171875
▁of 2.23046875
▁subject 3.158203125
iveness 3.703125
▁and 1.3046875
▁bias 1.7666015625
, 2.197265625
▁especially 1.958984375
▁regarding 3.603515625
▁people 5.38671875
▁in 3.5703125
▁severe 2.31640625
▁pain 0.61962890625
▁and 2.474609375
▁un 5.58984375
stable 0.970703125
▁emot 0.65576171875
ional 0.074462890625
▁condition 2.779296875
. 0.04766845703125
▁Perhaps 7.9609375
▁some 5.19140625
▁patients 1.58203125
▁tend 4.7265625
▁to 0.00766754150390625
▁ex 1.8974609375
agger 0.006412506103515625
ate 0.0013322830200195312
▁their 0.984375
▁de 3.69921875
press 1.69921875
ive 0.0595703125
▁state 2.443359375
▁or 1.7568359375
▁vice 5.5078125
▁vers 0.0184173583984375
a 6.079673767089844e-06
, 1.150390625
▁de 7.57421875
- 2.330078125
emph 0.46484375
as 0.002567291259765625
ize 0.0797119140625
▁serious 6.54296875
▁difficulties 5.3515625
. 0.78759765625
▁Because 6.234375
▁the 3.072265625
▁survey 4.8671875
▁responses 6.99609375
▁were 1.341796875
▁thoroughly 8.921875
▁anonymous 2.90625
, 0.254638671875
▁the 1.3193359375
▁research 0.92529296875
ers 0.150390625
▁were 2.6171875
▁unable 2.58203125
▁to 0.0013399124145507812
▁carefully 7.71875
▁analyze 2.802734375
▁each 2.564453125
▁patient 2.177734375
’ 0.580078125
s 0.0008749961853027344
▁reaction 3.630859375
▁and 1.306640625
▁compare 3.638671875
▁it 0.85498046875
▁to 0.74560546875
▁the 0.9658203125
▁actual 4.1015625
▁states 7.84375
▁of 0.84033203125
▁condition 6.859375
. 0.26953125
▁More 6.453125
▁accurate 2.998046875
▁answers 4.296875
▁could 1.7587890625
▁be 0.6201171875
▁obtained 1.048828125
▁by 1.4033203125
▁professional 5.609375
▁psych 1.2099609375
olog 0.3837890625
ists 0.0012655258178710938
▁via 7.01171875
▁personal 2.73046875
▁communication 4.05078125
▁and 1.8896484375
▁behavior 6.22265625
al 0.283447265625
▁analysis 2.16796875
. 0.270751953125
▁However 2.68359375
, 0.0002586841583251953
▁this 1.5224609375
▁method 2.23828125
▁of 2.7265625
▁research 1.98046875
▁is 1.1015625
▁way 5.91015625
▁more 0.88330078125
▁resource 4.765625
- 0.2529296875
int 1.376953125
ensive 0.0222930908203125
▁and 0.391357421875
▁energy 10.7578125
- 0.0736083984375
consum 0.36962890625
ing 0.0020656585693359375
. 0.66796875
<0x0A> 0.372314453125
The 0.85498046875
▁study 1.5068359375
▁conducted 4.26953125
▁a 1.9345703125
▁correlation 6.34765625
▁type 9.09375
▁of 0.2176513671875
▁research 1.2939453125
▁with 3.396484375
▁variable 7.97265625
▁measures 0.9599609375
. 1.1767578125
▁It 1.2451171875
▁evaluated 4.59375
▁the 0.623046875
▁inter 5.8515625
dep 2.32421875
end 0.00016832351684570312
ence 0.00951385498046875
▁of 0.57568359375
▁various 3.203125
▁factors 0.7802734375
▁that 2.927734375
▁affected 3.912109375
▁the 0.439453125
▁physical 6.609375
▁and 0.24853515625
▁emot 0.5185546875
ional 0.00012302398681640625
▁condition 1.462890625
▁of 0.056365966796875
▁patients 0.783203125
▁experien 3.794921875
cing 3.5762786865234375e-06
▁chron 0.41162109375
ic 0.00021159648895263672
▁pain 0.0282135009765625
. 0.111328125
▁For 3.4609375
▁example 0.402099609375
, 0.0007843971252441406
▁the 1.0634765625
▁survey 4.5078125
▁showed 3.4140625
▁that 0.5185546875
▁the 1.9296875
▁ratio 7.18359375
▁of 0.11505126953125
▁female 2.791015625
▁patients 1.0546875
▁was 1.0478515625
▁remark 7.79296875
ably 0.00013113021850585938
▁higher 0.18310546875
▁in 3.251953125
▁the 1.0283203125
▁op 3.736328125
i 2.349609375
ates 0.01099395751953125
▁group 0.1192626953125
▁compared 2.294921875
▁to 0.03192138671875
▁the 0.60107421875
▁MM 0.293701171875
▁group 0.8330078125
. 0.219482421875
▁In 3.171875
▁turn 4.43359375
, 0.0006432533264160156
▁people 4.3046875
▁on 4.92578125
▁op 2.173828125
i 0.362060546875
ates 0.0030536651611328125
▁were 0.962890625
▁more 1.3232421875
▁likely 0.2142333984375
▁to 0.02313232421875
▁report 3.033203125
▁major 6.31640625
▁de 0.89892578125
press 0.845703125
ive 0.002887725830078125
▁dis 1.0205078125
orders 1.3369140625
. 1.748046875
<0x0A> 2.6171875
Part 5.75390625
icip 0.2342529296875
ants 0.05474853515625
▁were 2.119140625
▁rec 3.90234375
ru 0.00042724609375
ited 1.4424324035644531e-05
▁for 1.7392578125
▁six 0.431640625
▁months 0.008209228515625
▁at 0.56884765625
▁two 0.1168212890625
▁major 0.209228515625
▁pain 0.056060791015625
▁relief 0.043487548828125
▁cent 0.015625
ers 0.0009593963623046875
▁in 0.058441162109375
▁Israel 0.0140533447265625
. 0.1669921875
▁All 4.296875
▁patients 1.3310546875
▁experienced 3.888671875
▁chron 0.94140625
ic 0.00010144710540771484
▁pain 0.15625
▁for 1.7548828125
▁at 0.62548828125
▁least 0.0014524459838867188
▁ 1.7666015625
3 1.74609375
▁months 0.25341796875
. 1.27734375
▁The 1.2958984375
▁study 1.6103515625
▁included 1.8095703125
▁ 0.5830078125
8 3.03125
9 2.451171875
0 2.931640625
▁participants 1.40234375
, 1.5673828125
▁of 2.580078125
▁which 0.3994140625
▁ 0.10107421875
4 1.3193359375
7 2.513671875
4 2.59765625
▁( 3.103515625
5 0.10076904296875
9 5.03125
%) 0.68408203125
▁were 0.73046875
▁treated 3.587890625
▁sole 7.33984375
ly 0.0003197193145751953
▁with 0.270751953125
▁op 0.720703125
io 0.9814453125
ids 0.135009765625
, 0.568359375
▁ 1.13671875
3 1.2392578125
2 2.255859375
9 2.43359375
▁( 0.047088623046875
4 2.509765625
1 1.1318359375
%) 0.051513671875
▁were 1.55078125
▁treated 0.62890625
▁with 0.325927734375
▁MM 0.64990234375
, 0.248779296875
▁and 0.09124755859375
▁ 0.23193359375
7 1.9541015625
7 2.494140625
▁( 0.11322021484375
8 2.044921875
. 0.94091796875
6 2.53515625
%) 0.052764892578125
▁acquired 10.6328125
▁both 0.59326171875
▁( 5.04296875
Fe 9.921875
ing 1.033203125
old 0.5517578125
▁et 0.95556640625
▁al 0.017730712890625
., 0.1552734375
▁ 0.0160369873046875
2 0.00662994384765625
0 0.0003120899200439453
1 0.2186279296875
7 1.662109375
). 0.05682373046875
▁The 1.212890625
▁remaining 7.3828125
▁ten 6.703125
▁participants 1.208984375
▁who 5.04296875
▁did 2.203125
▁not 0.00492095947265625
▁receive 2.01953125
▁ph 4.29296875
arma 0.12841796875
ce 0.0007772445678710938
ut 1.3113021850585938e-06
ical 0.0021266937255859375
▁op 2.140625
io 0.1881103515625
ids 0.020416259765625
▁and 2.654296875
▁medical 1.69921875
▁mar 0.039703369140625
iju 0.0003006458282470703
ana 4.839897155761719e-05
▁were 0.490966796875
▁with 6.75
dra 0.056854248046875
wn 8.285045623779297e-05
▁from 0.23193359375
▁the 0.1827392578125
▁analysis 2.298828125
▁in 5.26953125
▁the 0.892578125
▁research 4.3359375
. 0.83740234375
▁Therefore 5.2578125
, 0.00743865966796875
▁it 3.455078125
▁is 1.5712890625
▁not 3.0546875
▁possible 0.873046875
▁to 0.00449371337890625
▁compreh 6.0
ens 0.08843994140625
ively 0.0108489990234375
▁compare 1.2724609375
▁patients 4.98828125
▁taking 3.95703125
▁medic 4.0234375
ations 0.4365234375
▁with 1.4013671875
▁those 0.8740234375
▁who 0.77734375
▁do 1.58984375
▁not 0.0038967132568359375
. 0.59619140625
<0x0A> 0.51708984375
Am 5.45703125
ong 0.00576019287109375
▁all 1.974609375
▁participants 1.0732421875
▁in 3.46484375
▁the 0.1549072265625
▁study 0.630859375
, 0.0421142578125
▁ 0.79248046875
4 1.892578125
2 2.26171875
. 1.380859375
2 2.24609375
% 0.044342041015625
▁suffered 3.95703125
▁from 0.04241943359375
▁de 1.7529296875
pression 0.27587890625
, 0.86474609375
▁and 1.1220703125
▁ 0.11224365234375
3 1.43359375
7 2.3828125
% 2.537109375
▁experienced 2.052734375
▁excess 7.0625
ive 0.0269622802734375
▁anx 0.19287109375
iety 0.0018596649169921875
. 0.320068359375
▁The 1.4189453125
▁pl 10.9609375
ur 0.61572265625
ality 0.0005946159362792969
▁of 0.10089111328125
▁de 2.638671875
press 1.265625
ive 0.03271484375
▁dis 2.435546875
orders 0.07232666015625
▁among 2.94140625
▁patients 1.1513671875
▁in 2.80078125
▁the 0.28955078125
▁op 0.6455078125
i 0.3623046875
ates 0.0011186599731445312
, 9.015625
▁medical 3.515625
▁mar 0.023468017578125
iju 0.0006847381591796875
ana 8.344650268554688e-06
, 0.1661376953125
▁and 0.08941650390625
▁mixed 1.5361328125
▁OP 11.5078125
MM 4.55078125
▁groups 0.56298828125
▁number 9.296875
ed 0.0196380615234375
▁ 0.1771240234375
5 1.9619140625
7 2.658203125
. 0.66064453125
1 2.48828125
%, 0.198974609375
▁ 0.0030651092529296875
2 2.10546875
2 2.65234375
. 0.11279296875
3 2.2734375
%, 0.04345703125
▁and 0.0477294921875
▁ 0.0016193389892578125
5 2.091796875
1 2.154296875
. 0.175048828125
4 1.638671875
%, 0.155029296875
▁respectively 0.023040771484375
. 0.233642578125
▁The 1.2900390625
▁pl 3.90625
ur 0.0108795166015625
ality 1.52587890625e-05
▁of 0.024139404296875
▁anx 0.42236328125
iety 0.0169525146484375
▁contained 10.6328125
▁ 0.2042236328125
4 1.150390625
8 2.36328125
. 0.18359375
4 2.19140625
% 2.08984375
▁among 2.505859375
▁OP 5.0
▁patients 6.08203125
, 0.267333984375
▁ 0.0809326171875
2 0.953125
1 2.470703125
. 0.1168212890625
5 2.08203125
% 0.02642822265625
▁among 0.473388671875
▁MM 0.0972900390625
▁patients 0.4814453125
, 0.0156707763671875
▁and 0.01514434814453125
▁ 0.025421142578125
3 1.2919921875
8 1.9541015625
. 0.1297607421875
7 2.435546875
% 0.01157379150390625
▁among 0.19970703125
▁OP 2.55859375
MM 0.134765625
▁participants 2.986328125
. 0.2193603515625
▁Pat 5.29296875
ients 0.0170135498046875
▁who 1.8359375
▁took 2.42578125
▁strong 9.8515625
▁op 0.81103515625
i 0.89208984375
ates 0.00324249267578125
▁were 1.2255859375
▁t 10.1015625
ended 0.9462890625
▁to 0.006725311279296875
▁place 10.0078125
▁their 1.8603515625
▁pain 1.2490234375
▁on 1.8515625
▁a 0.56103515625
▁scale 1.93359375
▁of 0.370361328125
▁ 0.1109619140625
9 2.59375
▁to 2.181640625
▁ 0.01190185546875
1 0.004100799560546875
0 0.007228851318359375
▁( 2.68359375
Fe 1.740234375
ing 0.0034046173095703125
old 0.000530242919921875
▁et 0.0152587890625
▁al 0.00144195556640625
., 0.0125885009765625
▁ 0.0012407302856445312
2 0.0002340078353881836
0 4.184246063232422e-05
1 0.0009512901306152344
7 0.00495147705078125
). 0.0121002197265625
▁They 4.1484375
▁were 1.693359375
▁also 0.81982421875
▁an 9.625
gu 5.00390625
ished 0.07958984375
▁em 6.32421875
otion 0.0010080337524414062
ally 0.0006341934204101562
▁and 1.0185546875
▁react 7.328125
ed 0.0215301513671875
▁rad 9.0625
ically 0.001049041748046875
▁neg 4.8984375
atively 0.0011997222900390625
▁to 0.1881103515625
▁almost 5.7265625
▁all 1.599609375
▁survey 3.76171875
▁questions 0.2366943359375
. 0.343017578125
▁Pat 3.935546875
ients 0.004184722900390625
▁who 1.29296875
▁took 1.8017578125
▁only 4.37109375
▁MM 0.36328125
▁or 2.736328125
▁mixed 2.41796875
▁medic 1.265625
ations 0.2110595703125
▁course 13.84375
▁had 2.529296875
▁a 1.4130859375
▁significantly 2.970703125
▁more 3.09765625
▁stable 2.376953125
▁emot 0.81298828125
ional 0.0008559226989746094
▁state 0.62109375
▁and 1.1435546875
▁cop 6.84765625
ed 0.0183868408203125
▁with 0.3212890625
▁pain 0.8291015625
▁more 1.7919921875
▁manage 6.55078125
able 1.3369140625
. 0.27392578125
<0x0A> 0.182373046875
One 4.8359375
▁of 0.2021484375
▁the 0.0029773712158203125
▁major 2.681640625
▁limitations 2.34765625
▁is 3.126953125
▁the 0.455322265625
▁ins 4.71484375
u 0.06964111328125
fficient 0.06707763671875
ly 3.505859375
▁high 3.009765625
▁response 3.54296875
▁rate 0.11151123046875
, 2.759765625
▁ 4.6796875
5 1.546875
7 3.001953125
% 2.01171875
▁instead 6.27734375
▁of 0.002613067626953125
▁ 0.430419921875
7 1.939453125
0 0.342529296875
% 1.4296875
▁( 2.111328125
Fe 0.59716796875
ing 0.0015726089477539062
old 0.00031447410583496094
▁et 0.010528564453125
▁al 0.00047898292541503906
., 0.007022857666015625
▁ 0.0013332366943359375
2 0.00010824203491210938
0 0.00011646747589111328
1 0.0004456043243408203
7 0.003025054931640625
). 0.01155853271484375
▁It 1.6845703125
▁can 3.146484375
▁be 0.77392578125
▁fairly 8.3671875
▁explained 1.546875
▁by 0.2010498046875
▁the 0.271728515625
▁weak 7.45703125
▁focus 6.99609375
▁of 0.693359375
▁respond 5.70703125
ents 0.1143798828125
▁who 3.47265625
▁have 3.912109375
▁overcome 8.3359375
▁severe 1.921875
▁pain 0.56640625
▁sens 7.671875
ations 0.2003173828125
▁and 0.93115234375
▁de 4.70703125
press 0.8173828125
ive 0.048004150390625
▁episodes 2.16796875
. 0.4677734375
▁It 2.751953125
▁is 0.72021484375
▁not 2.55859375
▁clear 3.576171875
▁how 1.9482421875
▁to 3.5
▁use 5.359375
▁these 2.75390625
▁statistics 3.796875
, 3.021484375
▁as 0.615234375
▁they 1.990234375
▁still 5.0390625
▁may 4.9296875
▁be 1.2509765625
▁relevant 6.078125
▁for 1.6728515625
▁the 1.8818359375
▁overall 4.7421875
▁analysis 2.8671875
. 0.92529296875
